Outcome in hemoglobin SC disease: A four-decade observational study of clinical, hematologic, and genetic factors
DOI 10.1002/ajh.10140
DR Powars A Hiti E Ramicone C Johnson L Chan 2002 Outcome in hemoglobin SC disease: a four decade observational study of clinical, hematologic and genetic factors Am J Hematol 70 206 215 1:CAS:528:DC%2BD38XlsF2ktL0%3D 10.1002/ajh.10140 12111766 (Pubitemid 34680681)
DOI 10.1002/(SICI)1096-8652(199607)52:3<189::AID-AJH9>3.0.CO;2-P
MH Steinberg RL Nagel C Lawrence V Swaminathan ZH Lu M Plonczynski A Harrell 1996 β-globin gene haplotype in HbSC disease Am J Hematol 52 189 191 1:STN:280:DyaK28zhtFeqsg%3D%3D 10.1002/(SICI)1096-8652(199607)52:3<189:: AID-AJH9>3.0.CO;2-P 8756085 (Pubitemid 26254854)
Differences in affinity of variant β chains for α chains: A possible explanation for the variation in the percentages of β chain variants in heterozygotes
EC Abraham THJ Huisman 1977 Differences in affinity of variant β-chains for α-chains: a possible explanation for the variation in the percentage of β-chain variants in heterozygotes Hemoglobin 1 861 873 1:CAS:528:DyaE1cXhvVCrtrw%3D 10.3109/03630267709003912 604319 (Pubitemid 8287376)
Maximum urine concentrating ability in children with Hb SC disease: Effects of hydroxyurea
DOI 10.1002/(SICI)1096-8652(200005)64:1<47::AID-AJH8>3.0.CO;2-1
R Iyer R Baliga RL Nagel C Brugnara K Kirchner S Hogan MH Steinberg 2000 Maximum urine concentrating ability in children with HbSC disease: effects of hydroxyurea Am J Hematol 64 47 52 1:STN:280:DC%2BD3c3ntlajuw%3D%3D 10.1002/(SICI)1096-8652(200005)64:1<47::AID-AJH8>3.0.CO;2-1 10815787 (Pubitemid 30228269)